Organovo Holdings, Inc. (NASDAQ:ONVO) Short Interest Update

Organovo Holdings, Inc. (NASDAQ:ONVO) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 340,900 shares, an increase of 96.9% from the December 15th total of 173,100 shares. Based on an average trading volume of 65,200 shares, the short-interest ratio is currently 5.2 days.

Shares of ONVO opened at $3.74 on Friday. The firm’s 50-day moving average price is $4.48 and its 200-day moving average price is $6.33. The firm has a market capitalization of $32.58 million, a price-to-earnings ratio of -2.75 and a beta of 0.49. Organovo has a 1-year low of $3.56 and a 1-year high of $23.92.

Organovo (NASDAQ:ONVO) last issued its quarterly earnings results on Monday, November 8th. The medical research company reported ($0.40) earnings per share (EPS) for the quarter.

A number of institutional investors have recently modified their holdings of the business. Moors & Cabot Inc. bought a new stake in shares of Organovo in the third quarter worth approximately $27,000. Millennium Management LLC bought a new stake in Organovo during the third quarter valued at approximately $94,000. Dimensional Fund Advisors LP bought a new stake in Organovo during the second quarter valued at approximately $116,000. Credit Suisse AG bought a new position in shares of Organovo in the second quarter worth approximately $147,000. Finally, Morgan Stanley boosted its position in shares of Organovo by 78.5% in the first quarter. Morgan Stanley now owns 27,211 shares of the medical research company’s stock worth $262,000 after purchasing an additional 11,968 shares during the period. 25.48% of the stock is owned by institutional investors and hedge funds.

Organovo Company Profile

Organovo Holdings, Inc engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.

Featured Article: How does a security become overbought?

Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.